Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» atopic dermatitis
atopic dermatitis
AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again
Fierce Pharma
Fri, 04/26/24 - 11:18 am
AbbVie
Rinvoq
Regeneron
Sanofi
Dupixent
atopic dermatitis
Incyte Inks $750M Deal to Buy Escient and Skin Disease Drug Candidates
BioSpace
Tue, 04/23/24 - 09:46 pm
Incyte
M&A
Escient Pharma
atopic dermatitis
FDA updates Sanofi’s Dupixent label for atopic dermatitis
Pharmaceutical Business Review
Wed, 01/17/24 - 09:26 am
Sanofi
Dupixent
FDA
atopic dermatitis
Allakos tumbles after skin disease drug fails mid-stage studies
Reuters
Tue, 01/16/24 - 09:24 am
Allakos
clinical trials
lirentelimab
dermatology
atopic dermatitis
Kymera’s protein degrader starts Phase II trial in atopic dermatitis
Clinical Trials Arena
Fri, 12/8/23 - 11:05 am
Kymera
Sanofi
protein degradation
clinical trials
atopic dermatitis
KT-474
Triveni Bio Launches with $92 Million Series A Financing to Advance Genetics-Informed Precision Medicines for the Treatment of Immunological and Inflammatory (I&I) Disorders
BioSpace
Thu, 10/26/23 - 10:33 am
Triveni Bio
funding
atopic dermatitis
AbbVie’s Rinvoq shows long-term sustained efficacy in atopic dermatitis
Clinical Trials Arena
Thu, 10/12/23 - 10:02 am
AbbVie
clinical trials
Rinvoq
atopic dermatitis
Aclaris finishes enrolment in atopic dermatitis Phase IIb trial of ATI-1777
Clinical Trials Arena
Wed, 10/4/23 - 11:10 am
Aclaris
ATI-1777
atopic dermatitis
JAK inhibitors
FDA Rejects Lilly’s Eczema Treatment Over Third-Party Manufacturing Issues
BioSpace
Mon, 10/2/23 - 10:36 am
Eli Lilly
lebrikizumab
atopic dermatitis
eczema
FDA
drug manufacturing
Nektar Flags Lilly’s Miscalculations in Rezpeg Atopic Dermatitis Trials
BioSpace
Mon, 08/7/23 - 10:51 am
Nektar Therapeutics
Eli Lill
Rezpeg
atopic dermatitis
Incyte’s trial of ruxolitinib cream meets primary endpoint
Clinical Trials Arena
Wed, 07/12/23 - 09:37 am
Incyte
ruxolitinib
clinical trials
pediatric
atopic dermatitis
Apogee Files for IPO with Promising Preclinical Immuno Asset
BioSpace
Sun, 06/25/23 - 09:37 pm
Paragon Therapeutics
IPOs
asthma
atopic dermatitis
Eli Lilly unveils new data from atopic dermatitis therapy trials
Clinical Trials Arena
Tue, 05/2/23 - 10:22 am
Eli Lilly
clinical trial
eczema
atopic dermatitis
lebrikizumab
BenevolentAI lead atopic dermatitis drug misses the mark
Pharmaphorum
Wed, 04/5/23 - 10:04 am
BenevolentAI
clinical trials
BEN-2293
atopic dermatitis
First Protein Degrader Tested Outside Oncology Yields Promising Results
BioSpace
Wed, 12/14/22 - 07:23 pm
Kymera Therapeutics
Sanofi
protein degradation
hidradenitis suppurativa
atopic dermatitis
KT-474
Weeks after starting, Amgen flashes yellow light on PhIII of $400M eczema bet
Endpoints
Thu, 08/4/22 - 11:03 am
Amgen
Kyowa Kirin
clinical trials
AMG 451
atopic dermatitis
Key data catalysts for the industry’s small players
EP Vantage
Fri, 07/1/22 - 09:35 am
Intercept Pharma
Akero
NASH
Kymera
atopic dermatitis
Zealand Pharma
short bowel syndrome
Relmada
Verona
Anavex
Assembly Biosciences
Aldeyra
FDA approves Sanofi and Regeneron’s Dupixent for atopic dermatitis in young children
Pharmaceutical Business Review
Wed, 06/8/22 - 10:44 am
Sanofi
Regeneron
FDA
pediatric
atopic dermatitis
Dupixent
Sidekick and Pfizer prep launch of DTx for atopic dermatitis
Pharmaforum
Fri, 05/20/22 - 10:21 am
Pfizer
Sidekick Health
digital therapeutics
DTx
atopic dermatitis
Lilly, after making $1B bet, posts 'compelling' late-phase data on Dupixent rival
Fierce Biotech
Mon, 03/28/22 - 10:20 am
Eli Lilly
lebrikizumab
Demira
Sanofi
Regeneron
Dupixent
atopic dermatitis
Pages
1
2
3
4
5
next ›
last »